In the FNA samples, an elevated expression of Ki‐67, P53, E‐cadherin or COX‐2, whether observed individually or in combination with a decreased expression of HER‐2, ER or PR, is a strong indicator of an adverse prognosis for canine mammary tumours. The gene discussed is ERBB2; the disease is breast cancer.